Caplin Point Laboratories Ltd vs Gennex Laboratories Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 06, 2026

Key Highlights

The Latest Trading Price of Caplin Point Laboratories Ltd is ₹ 1839 as of 06 May 15:30 . The P/E Ratio of Caplin Point Laboratories Ltd changed from 12.6 on March 2021 to 28.4 on March 2025 . This represents a CAGR of 17.65% over 5 yearsThe P/E Ratio of Gennex Laboratories Ltd changed from 12.2 on March 2021 to 15.1 on March 2025 . This represents a CAGR of 4.36% over 5 years The Market Cap of Caplin Point Laboratories Ltd changed from ₹ 3057 crore on March 2021 to ₹ 15222 crore on March 2025 . This represents a CAGR of 37.86% over 5 yearsThe Market Cap of Gennex Laboratories Ltd changed from ₹ 49.46 crore on March 2021 to ₹ 274.07 crore on March 2025 . This represents a CAGR of 40.84% over 5 years The revenue of Caplin Point Laboratories Ltd for the Dec '25 is ₹ 576.45 crore as compare to the Sep '25 revenue of ₹ 564.43 crore. This represent the growth of 2.13% The revenue of Gennex Laboratories Ltd for the Dec '25 is ₹ 42.96 crore as compare to the Sep '25 revenue of ₹ 39.3 crore. This represent the growth of 9.31% The ebitda of Caplin Point Laboratories Ltd for the Dec '25 is ₹ 223.35 crore as compare to the Sep '25 ebitda of ₹ 219.56 crore. This represent the growth of 1.73% The ebitda of Gennex Laboratories Ltd for the Dec '25 is ₹ 8.27 crore as compare to the Sep '25 ebitda of ₹ 7.56 crore. This represent the growth of 9.39% The net profit of Caplin Point Laboratories Ltd changed from ₹ 124.92 crore to ₹ 165.86 crore over 7 quarters. This represents a CAGR of 17.58% The net profit of Gennex Laboratories Ltd changed from ₹ 4.66 crore to ₹ 5.99 crore over 7 quarters. This represents a CAGR of 15.43% The Dividend Payout of Caplin Point Laboratories Ltd changed from 14.53 % on March 2021 to 13.43 % on March 2025 . This represents a CAGR of -1.56% over 5 yearsThe Dividend Payout of Gennex Laboratories Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Caplin Point Laboratories Ltd

Promoted by Mr. C. C. Paarthipan, Caplin Point Laboratories Limited was incorporated on April 16, 1990.
The Company is presently into the business of pharmaceuticals like producing, developing and marketing wide range of generic formulations and branded products and exporting to overseas market.
Its main research and development facilities are located in Tamil Nadu, India and has a manufacturing plant in Puducherry, India.
It has over 4000+ products registrations across the globe with over 650+ pharmaceutical formulations & over 36 therapeutic sections. Caplin markets a wide spectrum of pharmaceutical formulations and therapeutic segments in 23 countries.
In addition to LATAM and Africa, it is now serving the US, European Union and other regulated markets as well.

About Gennex Laboratories Ltd

Gennex Laboratories Limited, formerly known as Prudential Pharmaceuticals Limited was incorporated on June 25, 1985.
The Company got converted into a Public Limited Company and the name was changed from Prudential Pharmaceuticals Limited to Gennex Laboratories Limited in 2007. The Company is in the business of Manufacturing of Bulk Drugs, Intermediates and Biotech Products.
The Company has over the years added more capacity and infrastructure by way of an additional production block and equipment to the plant to handle more products and tonnages.
The Company is having a professionally managed team at every stage of its operations. Apart from these, Gennex is among the leading Vertically Integrated' pharmaceutical companies in India and has a robust product portfolio spread over major product segments encompassing Expectorants, Muscle Relaxants, Analgesic and Anti Fungal.

FAQs for the comparison of Caplin Point Laboratories Ltd and Gennex Laboratories Ltd

Which company has a larger market capitalization, Caplin Point Laboratories Ltd or Gennex Laboratories Ltd?

Market cap of Caplin Point Laboratories Ltd is 13,982 Cr while Market cap of Gennex Laboratories Ltd is 244 Cr

What are the key factors driving the stock performance of Caplin Point Laboratories Ltd and Gennex Laboratories Ltd?

The stock performance of Caplin Point Laboratories Ltd and Gennex Laboratories Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Caplin Point Laboratories Ltd and Gennex Laboratories Ltd?

As of May 6, 2026, the Caplin Point Laboratories Ltd stock price is INR ₹1839.5. On the other hand, Gennex Laboratories Ltd stock price is INR ₹10.06.

How do dividend payouts of Caplin Point Laboratories Ltd and Gennex Laboratories Ltd compare?

To compare the dividend payouts of Caplin Point Laboratories Ltd and Gennex Laboratories Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.